Table 3.

Treatment details and outcomes of post-treatment imaging for the 15 patient participants with histologically confirmed squamous cell carcinoma

Radiotherapy dose presented is delivered to the region containing the primary tumour. Post-treatment imaging was completed for 10 patients with one of them having an MRI scan rather than an FDG-PET scan due to the clinical circumstances. Highlighted rows indicate those patients with residual disease in the primary tumour on post-treatment imaging

CRT Concurrent chemoradiotherapy, FDG-PET¹⁸F-fluorodeoxyglucose positron emission tomography, RT Radiotherapy, SACT Systemic anticancer therapy